{"transactions":[{"id":2694350,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-28T01:42:30.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":49084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the stock options will vest on November 25, 2021."}],"balance_after":49084,"derivative":{"exercise_price":1.49,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":49084},"source":{"system":"sec-edgar","filing":"0001493152-21-013115","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221013115/ownership.xml","form_type":"4"}},{"id":2694349,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T01:42:30.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":38590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on November 25, 2021."}],"balance_after":533590,"source":{"system":"sec-edgar","filing":"0001493152-21-013115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221013115/ownership.xml","form_type":"4"}},{"id":2728535,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":139723,"kind":"person","name":"SCO CAPITAL PARTNERS LLC","position":1,"cik":"0001225978","reported_name":"SCO CAPITAL PARTNERS LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":2,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-05T20:05:38.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":80000,"price":2.0111,"value":160888.0,"ownership":{"direct":false,"nature":"SCO Capital Partners LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.035, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":11079292,"source":{"system":"sec-edgar","filing":"0001493152-21-010518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221010518/ownership.xml","form_type":"4"}},{"id":2778264,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":139723,"kind":"person","name":"SCO CAPITAL PARTNERS LLC","position":1,"cik":"0001225978","reported_name":"SCO CAPITAL PARTNERS LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":2,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-19T20:05:31.000Z","date":"2021-03-18","kind":"sale","acquired":false,"shares":80000,"price":2.2328,"value":178624.0,"ownership":{"direct":false,"nature":"SCO Capital Partners LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.13 to $2.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":11159292,"source":{"system":"sec-edgar","filing":"0001493152-21-006427","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221006427/ownership.xml","form_type":"4"}},{"id":2852552,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":139723,"kind":"person","name":"SCO CAPITAL PARTNERS LLC","position":1,"cik":"0001225978","reported_name":"SCO CAPITAL PARTNERS LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":2,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T21:05:34.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":120000,"price":2.9734,"value":356808.0,"ownership":{"direct":false,"nature":"SCO Capital Partners LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.71 to $3.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":11239292,"source":{"system":"sec-edgar","filing":"0001493152-21-004255","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004255/ownership.xml","form_type":"4"}},{"id":2870377,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":139723,"kind":"person","name":"SCO CAPITAL PARTNERS LLC","position":1,"cik":"0001225978","reported_name":"SCO CAPITAL PARTNERS LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":2,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-11T00:42:12.000Z","date":"2021-02-08","kind":"sale","acquired":false,"shares":240000,"price":3.0118,"value":722832.0,"ownership":{"direct":false,"nature":"SCO Capital Partners LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were\nsold in multiple transactions at prices ranging from $3.00 to $3.06, inclusive. The\nReporting Person undertakes to provide to the Issuer, any security holder, or the\nStaff of the SEC, upon request, full information regarding the number of shares\ndisposed at each separate price within the ranges set forth in this footnote."}],"balance_after":11359292,"source":{"system":"sec-edgar","filing":"0001493152-21-003285","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221003285/ownership.xml","form_type":"4"}},{"id":2905223,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":139723,"kind":"person","name":"SCO CAPITAL PARTNERS LLC","position":1,"cik":"0001225978","reported_name":"SCO CAPITAL PARTNERS LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":2,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-19T23:48:29.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":207117,"price":2.082,"value":431217.594,"ownership":{"direct":false,"nature":"SCO Capital Partners LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":11599292,"source":{"system":"sec-edgar","filing":"0001493152-21-001363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221001363/ownership.xml","form_type":"4"}},{"id":2905222,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":139723,"kind":"person","name":"SCO CAPITAL PARTNERS LLC","position":1,"cik":"0001225978","reported_name":"SCO CAPITAL PARTNERS LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":2,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-19T23:48:29.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":81283,"price":2.0187,"value":164085.9921,"ownership":{"direct":false,"nature":"SCO Capital Partners LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":11806409,"source":{"system":"sec-edgar","filing":"0001493152-21-001363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221001363/ownership.xml","form_type":"4"}},{"id":2905221,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":139723,"kind":"person","name":"SCO CAPITAL PARTNERS LLC","position":1,"cik":"0001225978","reported_name":"SCO CAPITAL PARTNERS LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":2,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-19T23:48:29.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":31600,"price":2.0004,"value":63212.64,"ownership":{"direct":false,"nature":"SCO Capital Partners LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":11887692,"source":{"system":"sec-edgar","filing":"0001493152-21-001363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221001363/ownership.xml","form_type":"4"}},{"id":2972212,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The options vest 25% on March 17, 2015, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":18.5,"expiration_date":"2024-03-07","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972211,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The options vest 25% on March 17, 2015, and in 36 equal monthly installments thereafter."}],"balance_after":80000,"derivative":{"exercise_price":1.28,"expiration_date":"2024-03-07","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972210,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vest 25% on May 11, 2016, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":7.34,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972209,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vest 25% on May 11, 2016, and in 36 equal monthly installments thereafter."}],"balance_after":125000,"derivative":{"exercise_price":1.28,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972208,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vest 25% on February 11, 2017, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":2.31,"expiration_date":"2026-02-11","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972207,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vest 25% on February 11, 2017, and in 36 equal monthly installments thereafter."}],"balance_after":200000,"derivative":{"exercise_price":1.28,"expiration_date":"2026-02-11","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972206,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest 25% on December 13, 2017, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":4.45,"expiration_date":"2026-12-13","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972205,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest 25% on December 13, 2017, and in 36 equal monthly installments thereafter."}],"balance_after":200000,"derivative":{"exercise_price":1.28,"expiration_date":"2026-12-13","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972204,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest 25% on December 14, 2018, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972203,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest 25% on December 14, 2018, and in 36 equal monthly installments thereafter."}],"balance_after":120000,"derivative":{"exercise_price":1.28,"expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972202,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":7.24,"expiration_date":"2029-04-09","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972201,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":120000,"derivative":{"exercise_price":1.28,"expiration_date":"2029-04-09","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972200,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":153244,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.45,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":153244},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972199,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":153244,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":153244,"derivative":{"exercise_price":1.28,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":153244},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972198,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":86756,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":3.2,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":86756},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":2972197,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:11.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":86756,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":86756,"derivative":{"exercise_price":1.28,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":86756},"source":{"system":"sec-edgar","filing":"0001493152-20-022146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022146/ownership.xml","form_type":"4"}},{"id":3029460,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":139723,"kind":"person","name":"SCO CAPITAL PARTNERS LLC","position":1,"cik":"0001225978","reported_name":"SCO CAPITAL PARTNERS LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":2,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-17T20:05:09.000Z","date":"2020-09-15","kind":"sale","acquired":false,"shares":1989,"price":2.0017,"value":3981.3813,"ownership":{"direct":false,"nature":"SCO Capital Partners LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020."}],"balance_after":11919292,"source":{"system":"sec-edgar","filing":"0001493152-20-017963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220017963/ownership.xml","form_type":"4"}},{"id":3032769,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":139723,"kind":"person","name":"SCO CAPITAL PARTNERS LLC","position":1,"cik":"0001225978","reported_name":"SCO CAPITAL PARTNERS LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":2,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-15T00:35:43.000Z","date":"2020-09-11","kind":"sale","acquired":false,"shares":4600,"price":2.0095,"value":9243.7,"ownership":{"direct":false,"nature":"SCO Capital Partners LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020."}],"balance_after":11921281,"source":{"system":"sec-edgar","filing":"0001493152-20-017788","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220017788/ownership.xml","form_type":"4"}},{"id":3032768,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":139723,"kind":"person","name":"SCO CAPITAL PARTNERS LLC","position":1,"cik":"0001225978","reported_name":"SCO CAPITAL PARTNERS LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":2,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-15T00:35:43.000Z","date":"2020-09-10","kind":"sale","acquired":false,"shares":73411,"price":2.0771,"value":152481.9881,"ownership":{"direct":false,"nature":"SCO Capital Partners LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.01 to $2.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020."}],"balance_after":11925881,"source":{"system":"sec-edgar","filing":"0001493152-20-017788","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220017788/ownership.xml","form_type":"4"}},{"id":3053210,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":139723,"kind":"person","name":"SCO CAPITAL PARTNERS LLC","position":1,"cik":"0001225978","reported_name":"SCO CAPITAL PARTNERS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":2,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T20:05:14.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":80000,"price":2.8539,"value":228312.0,"ownership":{"direct":false,"nature":"SCO Capital Partners LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.81 to $2.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020."}],"balance_after":11999292,"source":{"system":"sec-edgar","filing":"0001493152-20-016305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220016305/ownership.xml","form_type":"4"}},{"id":3138312,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-05-22T22:15:22.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":86756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":86756,"derivative":{"exercise_price":3.2,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":86756},"source":{"system":"sec-edgar","filing":"0001493152-20-009764","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220009764/ownership.xml","form_type":"4"}},{"id":3138311,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T22:15:22.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on March 31, 2021, and in three equal annual installments thereafter."}],"balance_after":495000,"source":{"system":"sec-edgar","filing":"0001493152-20-009764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220009764/ownership.xml","form_type":"4"}},{"id":3203729,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-18T20:36:40.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":153244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Contingent upon stockholder approval of an amendment to the 2015 Equity Incentive Plan (the \"2015 Plan\") at the Annual Meeting of Stockholders scheduled for May 20, 2020 to increase the number of shares available under the 2015 Plan, Mr. Rouhandeh will also be entitled to an additional grant of 86,756 stock options and a grant of 120,000 shares of restricted stock as soon as practicable after the amendment of the 2015 Plan. The stock options contingent upon stockholder approval will have an exercise price determined at the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards will vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":153244,"derivative":{"exercise_price":1.45,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":153244},"source":{"system":"sec-edgar","filing":"0001493152-20-004255","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220004255/ownership.xml","form_type":"4"}},{"id":3558041,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-11T23:06:13.000Z","date":"2019-04-09","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":120000,"derivative":{"exercise_price":7.24,"expiration_date":"2029-04-09","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001144204-19-019359","document":"tv518749_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000114420419019359/tv518749_4.xml","form_type":"4"}},{"id":4129540,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock option (right to buy)","published_at":"2017-12-18T21:16:28.000Z","date":"2017-12-14","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% accelerated vesting on change of control."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"After twelve months from the Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date."}],"balance_after":90000,"derivative":{"exercise_price":16,"exercise_date":"2019-01-14","expiration_date":"2027-12-14","underlying":"Common stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0000318306-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000031830617000001/primary_doc.xml","form_type":"4"}},{"id":4129539,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Srock option (right to buy)","published_at":"2017-12-18T21:16:28.000Z","date":"2017-12-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% accelerated vesting on change of control."}],"balance_after":30000,"derivative":{"exercise_price":16,"exercise_date":"2018-12-14","expiration_date":"2027-12-14","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000318306-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000031830617000001/primary_doc.xml","form_type":"4"}},{"id":4521332,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock option (right to buy)","published_at":"2016-12-16T00:36:36.000Z","date":"2016-12-13","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% accelerated vesting on change of control."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"After twelve months from Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date."}],"balance_after":200000,"derivative":{"exercise_price":4.45,"exercise_date":"2018-01-13","expiration_date":"2026-12-13","underlying":"Common stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000318306-16-000050","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000031830616000050/primary_doc.xml","form_type":"4"}},{"id":4521331,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":138982,"kind":"person","name":"Rouhandeh Steven H","position":1,"cik":"0001294343","reported_name":"Rouhandeh Steven H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock option (right to buy)","published_at":"2016-12-16T00:36:36.000Z","date":"2016-12-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% accelerated vesting on change of control."}],"balance_after":50000,"derivative":{"exercise_price":4.45,"exercise_date":"2017-12-13","expiration_date":"2026-12-13","underlying":"Common stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000318306-16-000050","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000031830616000050/primary_doc.xml","form_type":"4"}}]}